However, sell-offs present great opportunities to buy stocks with significant upside potential. Further, CRISPR Therapeutics ...

KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic ...

A phase 1/2 trial of CRISPR-engineered eTIL therapy KSQ-004EX for advanced solid tumors has dosed its first patient.

Eyeing a future of improved patient outcomes, the Medical College of Wisconsin is working to advance the prevention, ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.

An international team of researchers from Israel, the United States, and China has developed a genetic method to ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to ...

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

Using a novel method that gives a readout of which proteins are in specific locations within cells, UT Southwestern Medical ...

Investigators have developed STITCHR, a new gene editing tool that can insert therapeutic genes into specific locations without causing unwanted mutations. The system can be formulated completely as ...